STAT+: Why is Eli Lilly worth nearly $1 trillion?

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. We’ve got big FDA news to get into today — let’s get straight into it.

FDA names Richard Pazdur as top drug regulator  

The FDA yesterday said it has chosen Richard Pazdur, its longtime head cancer regulator, to lead its drug center, replacing George Tidmarsh.

Continue to STAT+ to read the full story…

​STAT Pharma: The science and business of new drug development

Leave a Reply

Your email address will not be published. Required fields are marked *